Frank MBA - Delivra Health Independent Chairman
DHBUF Stock | USD 0.01 0 19.49% |
Insider
Frank MBA is Independent Chairman of Delivra Health Brands
Age | 66 |
Web | https://delivrahealthbrands.com |
Delivra Health Management Efficiency
The company has return on total asset (ROA) of (0.2226) % which means that it has lost $0.2226 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0056) %, meaning that it generated substantial loss on money invested by shareholders. Delivra Health's management efficiency ratios could be used to measure how well Delivra Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Amber Shimpa | Goodness Growth Holdings | 44 | |
Gregory Gentile | Silver Spike Investment | 48 | |
Albert Zakes | Goodness Growth Holdings | N/A | |
Sam Gibbons | Goodness Growth Holdings | N/A | |
Joshua Rosen | Goodness Growth Holdings | 50 | |
Ivana Maric | Avicanna | N/A | |
Mba BEcon | Avicanna | N/A | |
Michael Schroeder | Goodness Growth Holdings | 56 | |
Stephen MD | Goodness Growth Holdings | 48 | |
Kyle MD | Goodness Growth Holdings | 48 | |
Harris Rabin | Goodness Growth Holdings | 48 | |
Frantz Devedec | Avicanna | N/A | |
Eric JD | Goodness Growth Holdings | 44 | |
Carlos Muete | Avicanna | N/A | |
Sonny Newman | C21 Investments | N/A | |
Scott Gordon | Silver Spike Investment | 63 | |
Roland Alvarez | Avicanna | N/A | |
Caitlin Johnston | Avicanna | N/A | |
Eric Shoemaker | C21 Investments | N/A | |
Christian Ocasio | Goodness Growth Holdings | 41 | |
John Heller | Goodness Growth Holdings | 54 |
Management Performance
Return On Equity | -1.01 | |||
Return On Asset | -0.22 |
Delivra Health Brands Leadership Team
Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gord Davey, CEO Pres | ||
Ann Gallery, Sr Communications | ||
CPA CMA, CFO Sec | ||
Matthew Wagar, VP Innovation | ||
Will Stewart, Sr Affairs | ||
CPA CGA, VP Fin | ||
Jonathan Hartshorn, Pres Satipharm | ||
Frank MBA, Independent Chairman |
Delivra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Delivra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.01 | |||
Return On Asset | -0.22 | |||
Profit Margin | (0.77) % | |||
Operating Margin | (0.66) % | |||
Current Valuation | 4.15 M | |||
Shares Outstanding | 252.62 M | |||
Shares Owned By Insiders | 21.99 % | |||
Price To Book | 1.66 X | |||
Price To Sales | 0.48 X | |||
Revenue | 8.14 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Delivra OTC Stock
Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.